Skip to main content

1 Result(s)

within Hajime Senjo Remove this filter Internal Medicine Remove this filter

and

  1. No Access

    Article

    Gilteritinib enhances graft-versus-leukemia effects against FLT3-ITD mutant leukemia after allogeneic hematopoietic stem cell transplantation

    Allogeneic hematopoietic stem cell transplantation (allo-SCT) is a potentially curative therapy for FLT3 internal tandem duplication mutant (FLT3-ITD+) acute myeloid leukemia, but relapse rate is high. A recent s...

    Zixuan Zhang, Yuta Hasegawa, Daigo Hashimoto, Hajime Senjo… in Bone Marrow Transplantation (2022)